Thomas, Alexandra http://orcid.org/0000-0001-9022-2229
Reis-Filho, Jorge S. http://orcid.org/0000-0003-2969-3173
Geyer, Charles E. Jr
Wen, Hannah Y.
Funding for this research was provided by:
Williams Family Chair in Breast Oncology
Breast Cancer Research Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA247749 01, P30CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 12 November 2022
Accepted: 19 May 2023
First Online: 23 June 2023
Competing interests
: A.T. reports Stock Ownership: Johnson & Johnson, Gilead Sciences, Bristol Myers Squibb, Pfizer, Doximity; Consulting or Advisory Role: BeyondSpring Pharmaceuticals, Lilly, Genentech, AstraZeneca; Research Funding: Sanofi (to the institution); Royalties UpToDate Royalties; J.S.R.-F. reports personal/consultancy fees from Goldman Sachs, Bain Capital, REPARE Therapeutics, Paige.AI and Personalis, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics, Paige.AI and Personalis, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Daiichi Sankyo, Merck, and AstraZeneca, outside the scope of this work. C.E.G. reports personal fees for advisory board membership from Exact Sciences; personal fees for consulting from Athenex; a role as Co-Chair of steering committees at Abbvie, Daiichi Sankyo and Genentech/Roche (non-financial interest); a role as coordinating PI for Genentech/Roche (non-financial interest); a non-renumerated role as Co-Chair of an executive committee and a steering committee at AstraZeneca; and a non-renumerated advisory role for AstraZeneca, Daiichi Sankyo, Genentech/Roche and Seagen. H.Y.W. reports Advisory Role for AstraZeneca. Additionally, author Jorge Reis-Filho is a Deputy Editor-in-Chief of <i>npj Breast Cancer</i> and played no role in the peer review or decision to publish this manuscript.